Ethyl 2-(2-aminothiazol-4-yl)acetate

Catalog No. :
ACORZA863
CAS No. :
53266-94-7
Molecular Formula :
C7H10N2O2S
Molecular Weight :
186.24

IUPAC Name:ethyl 2-(2-aminothiazol-4-yl)acetate

Ethyl 2-(2-aminothiazol-4-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g97%$79.00Login to see priceIn stockInquiry
1000g97%$111.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(2-aminothiazol-4-yl)acetate
IUPAC Nameethyl 2-(2-aminothiazol-4-yl)acetate
MDL No.MFCD00005330
Molecular FormulaC7H10N2O2S
Molecular Weight186.24
SMILESO=C(OCC)CC1=CSC(N)=N1
InChI KeySHQNGLYXRFCPGZ-UHFFFAOYSA-N
Synonym4LA52G9LVB | Hexylene glycol, analytical standard | HMS2450A11 | SMR000131752 | C01949 | ethyl-2-amino-4-thiazoleacetate | FT-0629553 | 2-(2-amino-thiazol-4-yl)-acetic acid ethyl ester | 2-(2-aminothiazol-4-yl)-acetic acid ethyl ester | IDI1_017548 | NCGC
CAS No.53266-94-7
PubChem CID104454

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACORZA863 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACHDEN753 route compound structure diagram
    ACHDEN75366659-20-9 In Stock
  4. Then
  5. ACORZA863 route product structure diagram
    ACORZA86353266-94-7 In Stock
Inquiry

2. ACORZA863 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACHDEN753 route compound structure diagram
    ACHDEN75366659-20-9 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACORZA863 route product structure diagram
    ACORZA86353266-94-7 In Stock
Inquiry

Comments (0)